» Articles » PMID: 2885105

Alpha 1-adrenoceptor Activity Regulates Release of Adenosine from the Ischemic Myocardium in Dogs

Overview
Journal Circ Res
Date 1987 May 1
PMID 2885105
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of this study was to test the hypothesis that alpha 1-adrenoceptor activity plays a key role in the release of adenosine from the ischemic myocardium. In 51 open-chest dogs, the left anterior descending coronary artery was perfused through an extracorporeal bypass tube from the carotid artery, and adenosine release into the local coronary vein was measured by the radioimmunoassay technique following the reduction of perfusion pressure for 20 minutes under alpha 1-, alpha 2-, and beta-adrenoceptor attenuations. Adenosine and lactate concentrations in the coronary arterial and venous blood sampled from the perfused area were determined, as well as fractional shortening. In the untreated condition, adenosine release was significantly (p less than 0.01) increased from 1.7 +/- 0.8 (SEM) to 8.8 +/- 1.3 nmol/100 g/min, 20 minutes after the onset of hypoperfusion (coronary blood flow: 28 +/- 2 ml/100 g/min) following the initial overshoot release. Neither beta- nor alpha 2-adrenoceptor attenuation affected the increase in adenosine release during hypoperfusion except for the slight attenuation of the overshoot release by beta-attenuation. In contrast, intracoronary infusions of prazosin and phentolamine during coronary hypoperfusion markedly attenuated (p less than 0.01) release of adenosine (1.8 +/- 0.7 nmol/100 g/min at 20 minutes). The extents of decreases in fractional shortening and lactate production were comparable between the untreated and alpha 1-adrenoceptor attenuation.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Persistent Coronary Vasomotor Tone During Myocardial Ischemia Occurs at the Capillary Level and May Involve Pericytes.

Le D, Zhao Y, Kaul S Front Cardiovasc Med. 2022; 9:930492.

PMID: 35811707 PMC: 9263193. DOI: 10.3389/fcvm.2022.930492.


Ranolazine may exert its beneficial effects by increasing myocardial adenosine levels.

Le D, Davis C, Wei K, Zhao Y, Cao Z, Nugent M Am J Physiol Heart Circ Physiol. 2019; 318(1):H189-H202.

PMID: 31834840 PMC: 8424540. DOI: 10.1152/ajpheart.00217.2019.


Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

OConnell T, Jensen B, Baker A, Simpson P Pharmacol Rev. 2013; 66(1):308-33.

PMID: 24368739 PMC: 3880467. DOI: 10.1124/pr.112.007203.


Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.

Jensen B, OConnell T, Simpson P J Cardiovasc Pharmacol. 2013; 63(4):291-301.

PMID: 24145181 PMC: 3980029. DOI: 10.1097/FJC.0000000000000032.


Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Jensen B, OConnell T, Simpson P J Mol Cell Cardiol. 2010; 51(4):518-28.

PMID: 21118696 PMC: 3085055. DOI: 10.1016/j.yjmcc.2010.11.014.